Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Human Gene Therapy
|
June 6, 2018
DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination
Xintao Hu, Antonio Valentin, Yanhui Cai, et al.
Frontiers in Immunology
|
April 9, 2025
AI discovery of TLR agonist-driven phenotypes reveals unique features of peripheral cells from healthy donors and ART-suppressed people living with HIV
Robert Were Omange, Samuel C Kim, Nikita S Kolhatkar, et al.
Infectious Diseases and Therapy
|
September 15, 2025
The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV
Yanan Zheng, Mary Wire, Robert Were Omange, et al.
Infectious Diseases and Therapy
|
September 15, 2024
A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod
Sharon A Riddler, Constance A Benson, Cynthia Brinson, et al.
International Journal of Geriatric Psychiatry
|
March 14, 2025
Norms of Hong Kong Brief Cognitive Test and the Utility for Screening Cognitive Impairment Among Chinese Older Adults
Yaonan Zheng, Jiahui Zhu, Nan Li, et al.
Science Translational Medicine
|
June 24, 2021
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy
Devi SenGupta, Cynthia Brinson, Edwin DeJesus, et al.
Nature Communications
|
March 4, 2025
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial
Lucia Bailón, José Moltó, Adrian Curran, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Human Gene Therapy
|
June 6, 2018
DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination
Xintao Hu, Antonio Valentin, Yanhui Cai, et al.
Frontiers in Immunology
|
April 9, 2025
AI discovery of TLR agonist-driven phenotypes reveals unique features of peripheral cells from healthy donors and ART-suppressed people living with HIV
Robert Were Omange, Samuel C Kim, Nikita S Kolhatkar, et al.
Infectious Diseases and Therapy
|
September 15, 2025
The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV
Yanan Zheng, Mary Wire, Robert Were Omange, et al.
Infectious Diseases and Therapy
|
September 15, 2024
A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod
Sharon A Riddler, Constance A Benson, Cynthia Brinson, et al.
International Journal of Geriatric Psychiatry
|
March 14, 2025
Norms of Hong Kong Brief Cognitive Test and the Utility for Screening Cognitive Impairment Among Chinese Older Adults
Yaonan Zheng, Jiahui Zhu, Nan Li, et al.
Science Translational Medicine
|
June 24, 2021
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy
Devi SenGupta, Cynthia Brinson, Edwin DeJesus, et al.
Nature Communications
|
March 4, 2025
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial
Lucia Bailón, José Moltó, Adrian Curran, et al.
Page
of 5